BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36308822)

  • 1. The DNA damage induced immune response: Implications for cancer therapy.
    Barros EM; McIntosh SA; Savage KI
    DNA Repair (Amst); 2022 Dec; 120():103409. PubMed ID: 36308822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
    Huang JL; Chang YT; Hong ZY; Lin CS
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery.
    Hayman TJ; Glazer PM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
    Storozynsky Q; Hitt MM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory signaling in genomically instable cancers.
    Talens F; Van Vugt MATM
    Cell Cycle; 2019 Aug; 18(16):1830-1848. PubMed ID: 31260383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
    Ye Z; Shi Y; Lees-Miller SP; Tainer JA
    Front Immunol; 2021; 12():797880. PubMed ID: 34970273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response.
    Ragu S; Matos-Rodrigues G; Lopez BS
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32283785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Damage and Cancer Immunotherapy: A STING in the Tale.
    Reisländer T; Groelly FJ; Tarsounas M
    Mol Cell; 2020 Oct; 80(1):21-28. PubMed ID: 32810436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation.
    Lopez-Pelaez M; Young L; Vazquez-Chantada M; Nelson N; Durant S; Wilkinson RW; Poon E; Gaspar M; Valge-Archer V; Smith P; Dovedi SJ
    Oncoimmunology; 2022; 11(1):2117321. PubMed ID: 36117525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-I Interferon Signaling in Fanconi Anemia.
    Landelouci K; Sinha S; Pépin G
    Front Cell Infect Microbiol; 2022; 12():820273. PubMed ID: 35198459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.
    Shi C; Qin K; Lin A; Jiang A; Cheng Q; Liu Z; Zhang J; Luo P
    J Exp Clin Cancer Res; 2022 Sep; 41(1):268. PubMed ID: 36071479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
    Khoo LT; Chen LY
    EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
    Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
    Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
    Beernaert B; Parkes EE
    Biochem Soc Trans; 2023 Apr; 51(2):539-555. PubMed ID: 36876871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
    Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
    Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control.
    Concannon K; Morris BB; Gay CM; Byers LA
    Mol Cell; 2023 Mar; 83(5):660-680. PubMed ID: 36669489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer.
    Li T; Chen ZJ
    J Exp Med; 2018 May; 215(5):1287-1299. PubMed ID: 29622565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.